Report Ocean’s recent report provides an accurate and comprehensive research analysis of the “Saudi Arabia Enteral Feeding Devices Market” with a primary focus on the present and past market ...

FDA approves Argenx's Vyvgart Hytrulo prefilled syringe for self-injection in gMG and CIDP, offering flexible dosing and expanding treatment options.

The FDA has approved a subcutaneous self-injectable for adults with generalized myasthenia gravis who are anti-acetylcholine ...

After proper training on subcutaneous injection technique, the prefilled syringe may be administered by the patient or caregiver.

Odyssey just launched an awesome new MTB tubeless tire liner that offers tunable air chambers with a lightweight package.

Already thriving with a successful launch of infused Vyvgart and its subcutaneous follow-on Vyvgart Hytrulo to the tune of $2 ...

Argenx's Vyvgart Hytrulo gets FDA approval for self-injection syringe, Opthea cuts 65% staff after trial failures, Protagonist reports psoriasis success, Pfizer cuts jobs, Keros reviews options ...

Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...

The U.S. Food and Drug Administration (FDA) has approved Dutch biotech argenx’s (NASDAQ:ARGX) (OTCPK:ARGNF) autoimmune disease drug Vyvgart Hytrulo, developed with Halozyme Therapeutics (NASDAQ:HALO), ...

The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.